Bill > SB832

This bill modifies provisions relating to collaborative practice arrangements between physicians and advanced practice registered nurses (APRNs) and physician assistants (PAs), expanding their ability to prescribe certain controlled substances. Key provisions include allowing APRNs and PAs to prescribe Schedule II controlled substances for hospice patients and patients of providers designated by the Department of Mental Health, expanding the types of controlled substances they can prescribe, and establishing detailed requirements for collaborative practice arrangements. The bill specifies that these healthcare professionals can prescribe Schedule III, IV, and V controlled substances, with limited authority for Schedule II medications (primarily hydrocodone). It outlines specific requirements for collaborative practice agreements, including provisions for geographic proximity, chart review, and supervision. The bill also addresses limitations on the number of collaborative practice arrangements a physician can have (no more than six full-time equivalent APRNs, PAs, or assistant physicians), and provides protections for both physicians and advanced practice providers in choosing collaborative relationships. Additionally, the bill includes educational and training requirements for prescriptive authority and mandates reporting of collaborative practice arrangements to the state board of registration for the healing arts.

Labor and Employment

https://www.senate.mo.gov/25info/BTS_Web/Bill.aspx?SessionType=R&BillID=6635808